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Objective: To examine the relationship between disease-speciﬁc quality of life (QOL) and
socio-demographic, medical, and psychosocial factors in Colombian patients with Rheuma-
toid Arthritis (RA).
Methods: One hundred and three RA patients recruited from ambulatory centers in
Neiva, Colombia were administered the Disease Activity Scale 28 (DAS-28), QOL-RA, Zung
Self-Rating Depression Scale, State-Trait Anxiety Inventory (STAI), Interpersonal Support
Evaluation List-12 (ISEL-12), and Symptom Checklist-90 Revised (SCL-90R).
Results: Lower QOL-RA was associated with lower socio-economic status (r = 0.26, p < 0.01),
higher likelihood of using opioids (t = −2.51, p < 0.05), higher likelihood of comorbid pul-
monary disease (t = −2.22, p < 0.05), and lower ISEL-12 sub-scales (r’s = 0.41–0.31, p’s < 0.001).
Lower QOL-RA was associated with higher DAS-28 (r = −0.28, p < 0.01), Visual Analog
Scale (VAS; r = −0.35, p < 0.001), Zung Depression (r = −0.72, p < 0.001), STAI-State (r = −0.66,
p  < 0.001), STAI-Trait (r = −0.70, p < 0.001), SCL-90R Global Severity Index (r = −0.50, p < 0.001),
SCL-90R Positive Symptom Total (r = −0.57, p < 0.001), and all SCL-90R sub-scales (r’s = −0.54 to
−0.21, p’s < 0.01). A multivariate linear regression model indicated that SES (B = 2.77, p < 0.05),
Zung Depression (B = −0.53, p < 0.001), STAI-State (B = −0.26, p < 0.05), and ISEL-12 Belonging
(B  = 1.15, p < 0.01) were independently associated with QOL-RA, controlling for signiﬁcantassociations.
Conclusions: More depressive and anxiety symptoms were independently associated withlower  disease-speciﬁc QOL, while higher perceptions of having people to do activities
with  (belonging social support) and higher SES were independently associated with higher
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disease-speciﬁc quality of life. Psychosocial factors impact QOL in RA above and beyond
disease activity. Additional research into the beneﬁts of psychosocial assessment of RA
patients and provision of comprehensive care to improve QOL is warranted.
© 2015 Elsevier Editora Ltda. All rights reserved.
Sintomas  depressivos  e  de  ansiedade  e  apoio  social  estão  associados  de
modo  independente  à  qualidade  de  vida  especíﬁca  da  doenc¸a em
pacientes  colombianos  com  artrite  reumatoide
Palavras-chave:
Artrite reumatoide
Qualidade de vida
Depressão
Ansiedade
Apoio social
r  e  s  u  m  o
Objetivo: Analisar a relac¸ão entre a qualidade de vida (QV) especíﬁca da doenc¸a e fatores
sociodemográﬁcos, clínicos e psicossociais em pacientes colombianos com artrite reuma-
toide (AR).
Métodos: Recrutaram-se 103 pacientes com AR em centros ambulatoriais de Neiva, na
Colômbia. Eles responderam ao Disease Activity Scale 28 (DAS-28), QOL-RA, Escala de
Autoavaliac¸ão  da Depressão de Zung, Inventário de Ansiedade Trac¸o-Estado (Idate), Inter-
personal Support Evaluation List-12 (Isel-12) e Symptom Checklist-90 Revised (SCL-90R).
Resultados: Escores mais baixos de QOL-RA estiveram associados a uma pior condic¸ão
socioeconômica (CSE; r = 0,26, p < 0,01), maior probabilidade de usar opioides (t = −2,51,
p  < 0,05), maior probabilidade de doenc¸a pulmonar comórbida (t = −2,22, p < 0,05) e
pontuac¸ões  inferiores nas subescalas do ISEL-12 (r’s = 0,41–0,31, p’s < 0,001). Uma menor
pontuac¸ão  no QOL-RA esteve associada a escores mais elevados no DAS-28 (r = −0,28,
p  < 0,01), Escala Analógica Visual (EVA; r = −0,35, p < 0,001), Escala de Autoavaliac¸ão da
Depressão de Zung (r = −0,72, p < 0,001), Idate-Estado (r = −0,66, p < 0,001), Idate-Trac¸o
(r  = −0,70, p < 0,001), SCL-90R Índice de Gravidade Global (r = −0,50, p < 0,001), SCL-90R Total
de  Sintomas Positivos (r = −0,57, p < 0,001) e todas as subescalas do SCL-90R (r’s = −0,54
a  −0,21, p’s < 0,01). Um modelo de regressão linear múltipla indicou que a CSE (B = 2,77,
p  < 0,05), a Escala de Autoavaliac¸ão da Depressão de Zung (B = −0,53, p < 0,001), o Idate-Estado
(B  = −0,26, p < 0,05) e o Isel-12 Pertencimento (B = 1,15, p < 0,01) estavam independentemente
associados à pontuac¸ão no QOL-RA, mesmo quando controlados por associac¸ões signiﬁca-
tivas.
Conclusões: Mais sintomas depressivos e de ansiedade estiveram independentemente asso-
ciados a uma menor QV especíﬁca da doenc¸a, enquanto a percepc¸ão aumentada de ter
pessoas com quem fazer atividades (pertencimento, apoio social) e CSE mais elevados
estiveram independentemente associados a uma maior QV especíﬁca da doenc¸a. Os fatores
psicossociais impactam na QV na AR acima e além da atividade da doenc¸a. É necessária
pesquisa adicional acerca dos benefícios da avaliac¸ão psicossocial do paciente com AR e da
prestac¸ão  de cuidados abrangentes para melhorar a QV.
© 2015 Elsevier Editora Ltda. Todos os direitos reservados.
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A is a debilitating autoimmune disease whose symptoms
ause increased difﬁculty in carrying out normal, every-
ay activities. RA has a worldwide prevalence of 0.5–1% of
he population, affecting women more  than men  at a ratio
f 3:1 and increasing with age.1 The prevalence of RA in
atin America is estimated at 0.4%,2 while in Colombia, it
ay be even lower, at 0.1%.3 The public health burden of
he disease is quite high. Approximately 10 years ago, RA
as the second cause of loss of working years in women
etween ages 15 and 44 in Colombia.4 Subjective patient
nd physician measures are important predictors of RA
reatment response and future health outcomes,5 makingaccurate measurements in domains of quality of life, pain,
and psychological factors valuable for accurate and improved
prognoses.
Quality of life (QOL) in individuals with RA is poorer than
healthy controls. Compared to those without arthritis, peo-
ple with RA were 40% more  likely to report fair or poor
general health, 30% more  likely to need help with personal
care, and twice as likely to have a health-related activity
limitation.6 General measures of QOL, such as the Health
Assessment Questionnaire Disability Index (HAQ) and the
Short-Form 36 (SF-36), as well as disease-speciﬁc measures,
such as the RAQOL and the QOL-RA, all indicate poorer QOL
than controls.7–11
The inﬂuence of psychosocial factors on QOL in RA
has been documented in samples from various countries.
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Depressive symptoms and depression have been associ-
ated with worse QOL in patients with RA in cross-sectional
studies12–15 and found to be an independent predictor of QOL
at two-year follow-up.16 Anxiety has also been found to be
associated with poorer QOL.12,13,17 RA patients with a comor-
bid psychiatric disorder had lower QOL,18 and somatization,
in particular, was found to be associated with worse QOL,
independent of anxiety and depression.14 Positive social sup-
port has been associated with better QOL in patients with
RA in some cross-sectional studies,19 whereas problematic
social interactions, criticism, and/or a lack of social support is
associated with poorer QOL.20,21 Higher satisfaction with emo-
tional support independently predicted improved QOL in RA
patients,22 though this buffering effect appeared to decrease
over time.23
Much  of the prior research has focused on samples from
Anglo-Saxon cultures and the importance of psychosocial
factors (including depressive symptoms, anxiety, other psy-
chopathology, and social support) on QOL in Latin Americans
with RA has been less studied.24 The aim of the present
study is to determine the psychosocial factors associated with
disease-speciﬁc QOL in a sample of patients with RA from
Colombia and examine their independent contributions to
QOL in RA. A focus on the role of social support in a Colom-
bian sample with RA is novel, and it is hypothesized that social
support, in particular, may inﬂuence QOL differently than
in prior research in primarily Anglo-Saxon cultures because
Latin American values tend to align with collectivist ideals
and famililism.25
Patients  and  methods
Participants
The sample consisted of 103 individuals diagnosed with
Rheumatoid Arthritis (RA) according to the American Col-
lege of Rheumatology/European League Against Rheumatism
(ACR/EULAR) Collaborative Initiative 2010 Rheumatoid Arthri-
tis Classiﬁcation Criteria.26 All patients aged 18 to 79 who
visited ambulatory centers in Neiva, Colombia between
December 2012 and June 2013 to be evaluated by a rheumatolo-
gist or internal medicine specialist and were cognitively able to
participate in the study were included. Any patient currently
hospitalized, with a comorbid neurological or psychiatric dis-
order interfering with independent decision making, with
terminal illness (deﬁned by a survival time of less than six
months), or with a history of alcohol or other drug abuse was
excluded from this study.
Procedure
Patients were assessed by a rheumatologist or internal
medicine specialist to determine eligibility. After sign-
ing an informed consent, the Disease Activity Scale-28
(DAS28)27 was administered, followed by a session with a
trained research assistant to complete demographic and
psychological scales. This study received ethics committee
approval. 0 1 5;5 5(5):406–413
Measures
Disease  Activity  Scale-28  (DAS28)
The Disease Activity Scale-28 (DAS28) is a composite measure
that consists of physical, emotional, and serological evalua-
tion. Measurements in this study included: (a) a 28 tender joint
count and a 28 swollen joint count, (b) the erythrocyte sedi-
mentation rate (ESR) as a measure of inﬂammation, and (c) a
Visual Analog Scale (VAS) rating of disease activity over the
prior week from 0 (not at all active) to 10 (extremely active).
A total score is calculated, with higher scores represent-
ing greater extent of disease activity.27 The following cut-off
points have been established: less than 2.6 indicates disease
remission, 2.6–3.2 indicates low disease activity, 3.2–5.1 indi-
cates moderate disease activity, and greater than 5.1 indicates
high disease activity. The DAS28 is highly correlated with
the original DAS (r > 0.94) and well-correlated with disability
as measured by the Health Assessment Questionnaire (HAQ;
r = 0.49) and the Short Form-36 (SF-36; r = −0.46).28
Quality  Of  Life-Rheumatoid  Arthritis  (QOL-RA)
The Quality of Life-Rheumatoid Arthritis (QOL-RA) is an eight-
item self-report questionnaire that evaluates physical ability,
interaction, pain, tension, overall health, arthritis-speciﬁc
QOL, social support, and mood on a Likert scale from 1 (very
poor) to 10 (excellent).29 Higher total scores indicate higher
disease-speciﬁc QOL. The Spanish version of the QOL-RA is
commonly used in Colombia and has good reliability, with a
Cronbach’s alpha of 0.89, very close to the English version of
0.90.29
State-Trait  Anxiety  Inventory  (STAI)
The State-Trait Anxiety Inventory (STAI) measures Trait
Anxiety (STAI-Trait), or stable anxiety, and State Anxiety (STAI-
State), or momentary anxiety. Each sub-scale consists of 20
symptoms evaluated on a 4-point Likert scale from 1 (not at
all or almost never) to 4 (very much so or almost always).
Some items reﬂect absence of anxiety and are reverse coded
in scoring. Higher total scores on each sub-scale reﬂect greater
anxiety.30 The Spanish measure has good to excellent reliabil-
ity (STAI-Trait alpha = 0.86, STAI-State alpha = 0.91).31
Interpersonal  Support  Evaluation  List  (ISEL-12)
The Interpersonal Support Evaluation List (ISEL-12) is a short-
ened version of a 40 item scale.32 The ISEL-12 assesses
perceived availability and potential for social interaction and
support. Half of the items are positive afﬁrmations, while
the other half are negative. The ISEL-12 has three subscales
of four items each: (1) the subscale “tangible” evaluates
the perceived availability of material aid; (2) the subscale
“appraisal” assesses the perceived availability of people with
whom the individual may share his/her problems; and (3)
the subscale “belonging” assesses the perceived availability
of individuals with whom to engage in activities. The indi-
vidual rates each items on a scale from 1 (deﬁnitely false)
to 4 (deﬁnitely true). Higher scores indicate higher levels
of perceived social support. The measure has been vali-
dated in the Spanish-speaking population with good reliability
(alpha = 0.70).33
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Table 1 – Socio-demographic characteristics of the
sample (n = 103).
% (n) Mean (SD)
Age 53.8 (12.7)
Gender (female) 85.4% (88)
Marital status
Single 12.6% (13)
Married 63.1% (65)
Divorced/separated 12.6% (13)
Widowed 11.7% (12)
Education
Primary/elementary school or less 39.9% (41)
High school 42.7% (44)
Technical studies or degree 10.6% (11)
University studies or degree 6.8% (7)
Socio-economic level
1 17.5% (18)
2 68.0% (70)
3 12.6% (13)
4 1.0% (1)
5 1.0% (1)
QOL [mean QOL-RA = 50.50(12.10) with a maximum of 80
points total]. They also reported average depressive symp-
tom and anxiety scores [mean Zung = 44.14(7.40) out of 80,
Table 2 – Medical characteristics of the sample.
% (n) Mean (SD)
Disease Activity Scale 28 (DAS28) 4.87 (1.46)
Severe (>5.1) 45.6% (47)
Moderate (3.2–5.1) 38.8% (40)
Low (2.6–3.2) 8.7% (9)
Remission (<2.6) 6.8% (7)
Visual Analog Scale (VAS) for DAS28 6.29 (2.68)
Number of years with disease 12.97 (11.63)
Early Rheumatoid Arthritis (≤3
years)
20.4% (21)
Total medications, mean (SD) 3.03 (0.88)
Non-Steroidal
Anti-Inﬂammatory Drugs
91.3% (94)
Disease Modifying
Anti-Rheumatic Drugs
77.7% (80)
Steroids 76.7% (79)
None 49.5% (51)
Biologic Therapy 44.7% (46)
Other 5.8% (6)
Opioids 4.9% (5)
Total comorbidities, mean (SD) 0.84 (1.02)
Hypertension 28.2% (29)r e v b r a s r e u m a t o l
ung  Self-Rating  Depression  Scale
he Zung Self-Rating Depression Scale was designed to eval-
ate the level of depression in patients diagnosed with a
epressive disorder.34 The Zung consists of 20 items repre-
enting the affective, psychological, and somatic symptoms
f depression. There are 10 positively worded items and 10
egatively worded items assessed on a scale of 1 (little of
he time) to 4 (most of the time).34 The Zung has been vali-
ated in Colombia with good reliability (alpha = 0.85).35 In the
resent study, the total score on the Zung was used to repre-
ent depressive symptoms on a continuum.
ymptom  Checklist-90-Revised  (SCL-90R)
he Symptom Checklist-90-R (SCL-90R) evaluates a broad
ange of psychological problems and psychopathology.36 The
cale consists of 90 symptoms assessed on a ﬁve-point Lik-
rt scale from 0 (not present or bothersome) to 4 (very
resent or bothersome). The items are grouped into the fol-
owing nine dimensions: somatization, obsessive–compulsive,
nterpersonal sensitivity, depression, anxiety, hostility, pho-
ic anxiety, paranoid ideation, and psychoticism. The scale
ncludes a Global Severity Index (GSI) to indicate the gen-
ral level of distress caused by the symptoms, a Positive
ymptom Distress Index (PSDI) to measure the intensity
f symptoms experienced, and a Positive Symptom Total
PST) to report the self-reported total number of 90 possible
ymptoms assessed.36 Higher scores indicate more  symp-
oms and/or more  distress. The SCL-90R has been validated
n Colombia with good reliability across various samples
alpha’s = 0.77–0.90).37
tatistical  analyses
he data were analyzed using IBM SPSS Statistics for Win-
ows, Version 20.0 (IBM Corporation, 2011). Frequencies and
escriptive statistics were calculated for socio-demographic
nd medical characteristics. Pearson correlations and t-
ests were conducted to examine the bivariate relationships
etween socio-demographics, medical characteristics, and
sychosocial factors and QOL-RA. A multivariate linear regres-
ion analysis was conducted on QOL-RA using the factors
ound to be signiﬁcant in bivariate analyses as predictors.
esults
able 1 describes the socio-demographic characteristics of the
ample (n = 103), which primarily consisted of married (63.1%,
 = 65) women (85.4%, n = 88) with an average age of 54 years.
ighty-ﬁve percent of the sample represented the bottom-
ost socio-economic levels in the country (levels 1–2), with
6.9% gainfully employed. Table 2 describes the medical char-
cteristics of the sample. Approximately 85% of the sample
ad moderate to high disease activity28 and had been liv-
ng with the disease for an average of 13 years. The average
A patient took three medications, with the majority tak-
ng non-steroidal anti-inﬂammatory drugs (NSAIDS) (91.3%,
 = 94), disease modifying anti-rheumatic drugs (DMARDS)
77.7%, n = 80), and steroids (76.7%, n = 79). One person was on
nti-depressant medication, and another on anticonvulsant6 0.0% (0)
Gainfully employed 36.9% (38)
medication. Approximately half (n = 52) had a co-morbidity,
most commonly hypertension (28.2%, n = 29).
Participants reported average levels of disease-speciﬁcOther 21.4% (22)
Cardiac disease 14.6% (15)
Diabetes 8.7% (9)
Pulmonary disease 4.9% (5)
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Table 3 – Bivariate relationships between
socio-demographic and medical characteristics and
QOL-RA.
Socio-demographic and medical
characteristics
Statistical
test  valuea
p value
Age −0.03 0.76
Gender 0.38 0.71
Marital status 0.37 0.72
Education 0.13 0.19
Socio-Economic Statusb 0.26 0.008
Gainfully employed −0.57 0.57
Disease Activity Scale 28 (DAS28) scoreb −0.28 0.004
Visual Analog Scale DAS28 scorec −0.35 <0.001
Number of years with disease −0.01 0.96
Early Rheumatoid Arthritis −0.92 0.36
Total medications 0.03 0.76
Biologic Therapy 1.24 0.22
Disease Modifying Anti-Rheumatic Drugs 0.19 0.85
Steroids 0.21 0.83
Non-Steroidal Anti-Inﬂammatory Drugs −1.72 0.11
Opioidsd −2.51 0.014
Other 1.50 0.14
Total comorbidities −0.05 0.65
None 0.17 0.87
Hypertension −0.17 0.86
Diabetes 0.44 0.66
Cardiac disease −0.54 0.59
Pulmonary diseased −2.22 0.03
Other 1.64 0.10
a If the independent variable was continuous, r value of a Pear-
son correlation was provided. If the independent variable was
categorical, t value of the independent t test was provided.
b p < 0.01.
Table 4 – Bivariate relationships between psychosocial
factors and QOL-RA.
Psychosocial factor Statistical
test valuea
p value
Zung Depressionb −0.72 <0.001
State-Trait Anxiety
Inventory-Stateb
−0.66 <0.001
State-Trait Anxiety
Inventory-Traitb
−0.70 <0.001
Interpersonal Support Evaluation
List (ISEL) totalb
0.42 <0.001
ISEL Appraisalb 0.31 <0.001
ISEL Belongingb 0.41 <0.001
ISEL Tangibleb 0.38 <0.001
Symptom Checklist-90-Revised
(SCL-90R) Global Severity Indexb
−0.50 <0.001
SCL-90R Positive Symptom Totalb −0.57 <0.001
SCL-90R Positive Symptom
Distress Index
−0.10  0.33
SCL-90R Somatizationb −0.45 <0.001
SCL-90R Obsessive–Compulsiveb −0.36 <0.001
SCL-90R Interpersonal Sensitivityb −0.33 <0.001
SCL-90R Depressionb −0.51 <0.001
SCL-90R Anxietyb −0.54 <0.001
SCL-90R Hostilityb −0.37 <0.001
SCL-90R Phobic Anxietyb −0.42 <0.001
SCL-90R Paranoid Ideationc −0.21 0.03
SCL-90R Psychoticismd −0.30 0.002
a If the independent variable was continuous, r value of a Pear-
son correlation was provided. If the independent variable was
categorical, t value of the independent t test was provided.
b p < 0.001.c p < 0.001.
d p < 0.05.
STAI-State = 35.26(10.21) out of 80, and STAI-Trait = 38.39(9.72)
out of 80]. Social support was high, with ISEL totals of
41.66(6.08) out of 48. Patients endorsed an average of
23.13(14.75) of the 90 symptoms on the SCL-90R (PST) with
average severities [1.51(0.44), range 0–4; PSDI], and overall
severities for the 90 items of 0.42(0.35) on a 0–4 scale (GSI).
Table 3 shows the bivariate relationships between socio-
demographic and medical characteristics and QOL-RA.
Although age, gender, marital status and education were not
signiﬁcantly associated with QOL-RA, socio-economic status
(SES) was positively correlated with QOL-RA scores (r = 0.26,
p < 0.01). DAS and VAS scores were negatively associated with
QOL-RA (r = −0.28, p < 0.01 and r = −0.35, p < 0.001). Opioid use
and presence of pulmonary disease were negatively associ-
ated with QOL-RA (t = −2.51, p < 0.05 and t = −2.22, p < 0.05),
but number of years with disease, total medications, total
comorbidities, other speciﬁc medication use, and other spe-
ciﬁc comorbidities were not related to QOL-RA in this sample.
Table 4 shows the bivariate relationships between psy-
chosocial factors and QOL-RA. Although SCL-90R PSDI was
not correlated with QOL-RA, all other psychosocial meas-
ures were signiﬁcant. Zung Depression total, STAI-State,
and STAI-Trait were signiﬁcantly negatively associated with
QOL-RA (r = −0.72, p < 0.001; r = −0.66, p < 0.001 and r = −0.70,
p < 0.001, respectively). The ISEL total and each three subscales
of appraisal, belonging, and tangible, were all signiﬁcantlyc p < 0.05.
d p < 0.01.
positively correlated with an increase in QOL-RA (r = 0.42,
p < 0.001; r = 0.31, p < 0.001; and r = 0.41, p < 0.001, respectively).
SCL-90R GSI and PST were signiﬁcantly negatively corre-
lated with QOL-RA (r = −0.50, p < 0.001 and r = −0.57, p < 0.001,
respectively). All subscales of the SCL-90R were signiﬁcantly
negatively correlated with QOL-RA.
The results of the multivariate linear regression model are
shown in Table 5. SES, Zung Depression, STAI-State Anxi-
ety, and ISEL Belonging scores were independently associated
with QOL-RA scores, controlling for DAS, VAS, opioid use,
pulmonary disease, STAI-Trait Anxiety, ISEL Appraisal, ISEL
Tangible, SCL-90R GSI, and SCL-90R PST scores. Higher SES and
ISEL Belonging sub-scale scores were associated with higher
QOL-RA scores (B = 2.77, p < 0.05 and B = 1.15, p < 0.01, respec-
tively), while higher Zung Depression and STAI-State Anxiety
scores were associated with lower QOL-RA scores (B = −0.53,
p < 0.001 and B = −0.26, p < 0.05, respectively). The Zung Depres-
sion Scale score was the factor most highly independently
associated with QOL-RA (Standardized Beta = −0.32).
Discussion
In this sample, more  depressive and anxiety symptoms were
independently associated with lower disease-speciﬁc QOL,
while more  positive perceptions of having people to do things
with (‘belonging’ social support) and higher socio-economic
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Table 5 – Factors independently associated with QOL-RA.
Factor Unstandardized B Standardized Beta p value
Socio-Economic Statusa 2.77 0.15 0.01
Disease Activity Scale 28 (DAS28) −0.52 −0.06 0.45
Visual Analog Scale DAS28 score −0.08 −0.02 0.84
Opioid use 3.36 0.06 0.33
Pulmonary disease 2.83 0.05 0.39
Zung Depressionb −0.53 −0.32 <0.001
State-Trait Anxiety Inventory – Statea −0.26 −0.22 0.02
State-Trait Anxiety Inventory – Trait −0.27 −0.21 0.07
Interpersonal Support Evaluation List (ISEL) – Appraisal −0.60 −0.12 0.18
ISEL Belongingc 1.15 0.23 0.005
ISEL Tangible 0.38 0.07 0.43
Symptom Checklist-90-Revised (SCL-90R) Global Severity Index 8.11 0.24 0.10
SCL-90R Positive Symptom Total −0.21 −0.26 0.07
a p < 0.05.
b p < 0.001.
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tatus were independently associated with higher disease-
peciﬁc QOL. Depressive symptoms, in particular, were most
trongly related to QOL in this group of Colombian RA patients.
sychosocial factors of RA patients affect well-being above and
eyond the inﬂuence of disease activity.
These results are similar to prior research indicating
n independent relationship between depressive symptoms
nd decreased general physical or mental health QOL in
ndividuals with RA.13–15 The ﬁndings of the present study
eplicate those of Nas and colleagues, who found depres-
ive and anxiety symptoms associated with poorer RA-speciﬁc
OL.12 Finally, Rupp and colleagues identiﬁed that depres-
ive symptoms predicted mental health QOL after taking into
ccount disease activity,16 while the present study extends
his research to indicate that depressive and anxiety symp-
oms are associated with disease-speciﬁc QOL (including
hysical, mental, and social impacts) independent of disease
ctivity. The clinical implications suggest potential value in
creening RA patients for emotional distress. For instance,
he Hamilton Anxiety and Depression Scale (HADS) is a 14-
tem instrument that is considered to be the gold standard in
heumatoid practice and has been translated and normed for
se in Colombia.38 However, future research should validate
he use of this scale in Colombian RA patients.
Social support, and speciﬁcally the perception that oth-
rs are available to do things with (ISEL belonging sub-scale),
as found to enhance disease-speciﬁc QOL in RA above and
eyond other socio-demographic, medical, and psychological
actors. Prior research suggests that supportive relationships
re beneﬁcial to individuals with RA,19 and that the per-
eption of adequate and positive social support enhances
dherence to treatment regimens, rehabilitation, and overall
ealth outcomes,39 which may explain higher QOL. One study
ound the social dimension of QOL-RA in Colombia to be much
igher compared to the US.40 It is possible that ‘belonging’
ocial support – having someone to participate in activities
ike lunch or a day trip – is more  available and/or highly val-
ed in Colombian culture, which tends to be more  collectivist
han individualist.25 The fairly constant availability of com-
anionship in Latino cultures may mean that the impact of alack of social support on QOL is felt much more  than in Anglo
cultures. In other words, the measure of ‘belonging’ social sup-
port may be more  sensitive in Latin America. Future research
on the role of social support in this socio-cultural context may
help to elucidate the positive and negative impact of compan-
ionship, interaction, and assistance in patients dealing with
RA, the resulting impact on QOL and other health outcomes,
and possible mechanisms of action.
The ﬁndings of the present study should be interpreted in
light of the following caveats. The sample was from a rural
town in Colombia and the ﬁndings can only be generalized to
this speciﬁc group. However, the fact that the sample was of
low SES makes it representative of much of the general popu-
lation in Latin America and is a strength of the current study.
Because of the cross-sectional nature of the study design, one
cannot infer a cause–effect relationship and future longitu-
dinal studies are needed. Psychosocial factors likely impact
QOL, but poor QOL can also increase depressive symptoms and
anxiety. The Zung Depression Scale was selected as a mea-
sure of depression for this study because it has been validated
in Colombia; however, it is possible that their RA symptoms
may have resulted in artiﬁcially high depression scores. It is
of note that analyses with a second measure of depression
administered in this study [the Patient Health Questionnaire-
9 (PHQ-9), a rapid screening tool evaluating the frequency of
nine key depressive symptoms over the prior two weeks]41
produced the same multivariate model, suggesting that the
observed relationship is not simply due to the items asked on
the Zung self-report scale.
Given the importance of psychosocial factors on QOL  in RA
patients across numerous studies (including this one), poten-
tial interventions to improve depressive symptoms, anxiety,
and social support could be considered. Cognitive behavioral
therapy (CBT), for instance, has been shown to signiﬁcantly
reduce depressive symptoms and anxiety compared to routine
medical management in RA.42 Additional research into the
development and evaluation of cost-effective, culturally sensi-
tive psychosocial interventions may be warranted. Given that
companionship / belonging social support can positively inﬂu-
ence perception of disease-related QOL in this sample, health
 o l . 2
r
1
1
1
1
1
1
1
1
1
1
2
2
2
2412  r e v b r a s r e u m a t
professionals may not need to play a large role in psychoso-
cial treatment strategies. For instance, future research could
examine the impact of providing opportunities for social inter-
action with peers who  share similar symptoms and concerns,
working with family members to provide additional support
to the RA patient, and/or scheduling group activities for the
social network.
Conclusion
This study is one of few examining associations between
psychosocial factors and QOL among RA patients in Latin
America. Depressive symptoms, anxiety, companionship /
belonging social support, and SES were all independently asso-
ciated with disease-speciﬁc QOL, with depressive symptoms
having the largest association. A Pan American Consensus
Statement recently concluded that the psychosocial function-
ing of RA patients in Latin American must be addressed.2 This
study shows that emotional distress and social support inﬂu-
ence QOL above and beyond disease activity. It appears that
RA patients could beneﬁt from a focus on alleviating the emo-
tional distress associated with their chronic disease, as well
as the medical disease management provided by health pro-
fessionals, through more  comprehensive RA patient care.
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